申请人:Syntex (U.S.A.) LLC
公开号:US20030229121A1
公开(公告)日:2003-12-11
The invention provides compounds of Formula (I):
1
wherein: R
1
-R
5
, A, L, and X have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermediates useful for preparing them.
本发明提供了式(I)的化合物:1其中:R1-R5,A,L和X具有规范中定义的任何值,是CCR-3受体拮抗剂,包括它们的制药组合物,使用它们的方法,以及制备它们的方法和中间体。